FDA Inspection 1176597 — Daiichi Sankyo, Inc.
The FDA completed an inspection of Daiichi Sankyo, Inc. on July 15, 2022 in Basking Ridge, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Basking Ridge, NJ (United States)
Additional Details
Sponsor, Contract Research Organization